ATE164077T1 - Die verwendung von interleukin-6 zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von lymphocytic leukemia und b-zell lymphoma. - Google Patents

Die verwendung von interleukin-6 zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von lymphocytic leukemia und b-zell lymphoma.

Info

Publication number
ATE164077T1
ATE164077T1 AT92117953T AT92117953T ATE164077T1 AT E164077 T1 ATE164077 T1 AT E164077T1 AT 92117953 T AT92117953 T AT 92117953T AT 92117953 T AT92117953 T AT 92117953T AT E164077 T1 ATE164077 T1 AT E164077T1
Authority
AT
Austria
Prior art keywords
treatment
lymphocytic leukemia
interleukin
preparing
pharmaceutical composition
Prior art date
Application number
AT92117953T
Other languages
English (en)
Inventor
Dan Aderka
Yasmin Maor
David Wallach
Michel Revel
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE164077T1 publication Critical patent/ATE164077T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92117953T 1991-10-20 1992-10-20 Die verwendung von interleukin-6 zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von lymphocytic leukemia und b-zell lymphoma. ATE164077T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9980391A IL99803A (en) 1991-10-20 1991-10-20 Pharmaceutical compositions comprising interleukin-6 for the treatment of chronic lymphocytic leukemia and B-cell lymphomas

Publications (1)

Publication Number Publication Date
ATE164077T1 true ATE164077T1 (de) 1998-04-15

Family

ID=11062985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92117953T ATE164077T1 (de) 1991-10-20 1992-10-20 Die verwendung von interleukin-6 zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von lymphocytic leukemia und b-zell lymphoma.

Country Status (12)

Country Link
US (1) US5462731A (de)
EP (1) EP0538810B1 (de)
JP (1) JP2823453B2 (de)
AT (1) ATE164077T1 (de)
AU (1) AU660493B2 (de)
CA (1) CA2080504C (de)
DE (1) DE69224786T2 (de)
DK (1) DK0538810T3 (de)
ES (1) ES2114903T3 (de)
GR (1) GR3026423T3 (de)
IL (1) IL99803A (de)
ZA (1) ZA927965B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689451A4 (de) * 1993-03-19 1997-08-20 Immunex Corp Pharmazeutische zubereitungen, die einen liganden enthalten, der mit einem löslichen rezeptor komplexiert ist
US5641657A (en) * 1994-05-19 1997-06-24 Human Genome Sciences, Inc. DNA encoding an interleukin-6 splice variant
US6028050A (en) * 1996-11-27 2000-02-22 Tosoh Corporation Method for increasing platelets by administering soluble interleukin-6 receptor
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
ES2262680T3 (es) * 2000-09-14 2006-12-01 Ares Trading S.A. Uso de una quimera il-6r/il-6 en la enfermedad de huntington.
DE10107737A1 (de) * 2001-02-16 2002-09-05 S Rose John Christian Albrecht Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04500208A (ja) * 1988-08-26 1992-01-16 シェリング・コーポレーション インターロイキン―６で末端分化を誘導することによる骨髄性白血病の治療
AU639428B2 (en) * 1988-12-01 1993-07-29 Imclone Systems, Inc. Synthetic interleukin-6
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
US5087448A (en) * 1989-02-02 1992-02-11 The Board Of Regents Of The University Of Oklahoma Enhancing growth of megakaryocytes in mammals using interleuking 6
US5216128A (en) * 1989-06-01 1993-06-01 Yeda Research And Development Co., Ltd. IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
GR3026423T3 (en) 1998-06-30
AU660493B2 (en) 1995-06-29
CA2080504C (en) 2006-10-03
AU2636592A (en) 1993-04-22
IL99803A (en) 1997-02-18
IL99803A0 (en) 1992-08-18
ZA927965B (en) 1993-05-04
DE69224786T2 (de) 1998-07-09
ES2114903T3 (es) 1998-06-16
EP0538810B1 (de) 1998-03-18
JP2823453B2 (ja) 1998-11-11
US5462731A (en) 1995-10-31
DE69224786D1 (de) 1998-04-23
EP0538810A2 (de) 1993-04-28
EP0538810A3 (en) 1993-08-04
DK0538810T3 (da) 1998-12-21
JPH0725785A (ja) 1995-01-27
CA2080504A1 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
EP0176034A3 (en) Diaryl acetylenes, their preparation and use
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
IT1219002B (it) Dispositivo di regolazione d'altezza particolarmente per sedie tavoli e simili
ATE164077T1 (de) Die verwendung von interleukin-6 zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von lymphocytic leukemia und b-zell lymphoma.
DE3769691D1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
DE69034076D1 (de) Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
DE3467092D1 (en) Patient's positioning table
MX9205724A (es) Procedimiento para la copulacion reductora con pinacol, selectiva para diastereoisomeros, de a-aminoaldehidos homoquirales
IL67896A (en) Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
ES2017279A6 (es) Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas.
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE69029040D1 (de) Megakaryocytopoietischer faktor
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69103053D1 (de) Pharmazeutische Zubereitung für die Reifung von Prothymozythen.
DE3470741D1 (en) Azolylmethylcycloacetals, process for their preparation and their use as medicaments
DE59207886D1 (de) Vorrichtung zur Herstellung von Faltenbälgen
FR2525891B1 (fr) Dispositif de contention humaine equipe d'un referentiel
IT1204974B (it) Tavola d'appoggio in particolare per copiatrici
AT387962B (de) Verfahren zur herstellung von neuen n-((alkylamino)carbonyl)-n-(((alkylamino)carbonyl)oxy)acylamiden
ES1002569Y (es) Mesa de oficina perfeccionada
ES1012757Y (es) Mesa de oficina perfeccionada
SE8600960D0 (sv) Skrivplatta for hemiplegiker "barbro-plattan"
KR910001412U (ko) 브이씨알 및 디에이티의 공급릴 테이블

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee